Last reviewed · How we verify
NCT05888246
Measuring the Range of Cardiac Magnetic Parameters in Healthy Subjects by Magnetocardiogram
NA trial testing Magnetocardiogram in Healthy People in 412 participants. Completed in 14 May 2022.
14 May 2022
Quick facts
| Lead sponsor | Hangzhou Nuochi Life Science Co., Ltd. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 412 |
| Start date | 7 May 2022 |
| Primary completion | 14 May 2022 |
| Estimated completion | 14 May 2022 |
| Sites | 1 location across China |
Drugs / interventions tested
- Magnetocardiogram
Conditions studied
- Healthy People — all drugs for Healthy People →
Sponsor
Hangzhou Nuochi Life Science Co., Ltd.
Who can join
Adults 18 to 70, any sex, with Healthy People. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A prospective and observational clinical study of measuring the range of cardiac magnetic parameters in healthy people with the magnetocardiogram manufactured by Hangzhou Nuochi Life Science Co., LTD
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05888246
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Magnetocardiogram
Trials testing the same drug.
- NCT04352816 — Magnetocardiography (MCG) Parameters in the Prediction of Future ICD Therapy · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05888246 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hangzhou Nuochi Life Science Co., Ltd.
- Last refreshed: 28 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05888246.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing